What is the recommended treatment for H.pylori (Helicobacter pylori) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Treatment for H. pylori Infection

Bismuth quadruple therapy (PPI + bismuth + tetracycline + metronidazole) for 14 days is the recommended first-line treatment for H. pylori infection in regions with high clarithromycin resistance (>15-20%). 1

First-Line Treatment Options

Treatment selection should be based on regional antibiotic resistance patterns:

  1. High clarithromycin resistance regions (>15-20%):

    • Bismuth quadruple therapy for 14 days (85% eradication rate) 1
      • PPI + bismuth + tetracycline + metronidazole
    • Alternative: Concomitant non-bismuth quadruple therapy for 14 days (80% eradication rate) 1
      • PPI + clarithromycin + amoxicillin + metronidazole
  2. Low clarithromycin resistance regions (<15-20%):

    • Standard triple therapy for 14 days (85% eradication rate) 1
      • PPI + amoxicillin + clarithromycin
  3. FDA-approved regimens 2:

    • Triple therapy: 1g amoxicillin + 500mg clarithromycin + 30mg lansoprazole, twice daily for 14 days
    • Dual therapy: 1g amoxicillin + 30mg lansoprazole, three times daily for 14 days

Second-Line Treatment Options

After failure of first-line therapy:

  • If clarithromycin-based therapy failed: Use bismuth quadruple therapy or levofloxacin-based triple therapy 1, 3
  • If bismuth quadruple therapy failed: Use clarithromycin or levofloxacin-containing regimens 1, 3

Third-Line Treatment Options

For patients with two treatment failures:

  • Rifabutin-based triple therapy or high-dose dual therapy 1
  • After two failed therapies with confirmed adherence, H. pylori susceptibility testing should guide subsequent regimen selection 1

Important Administration Guidelines

  • Take medications at the start of a meal to minimize gastrointestinal intolerance 2
  • For optimal PPI effectiveness, administer 30 minutes before eating or drinking on an empty stomach 1
  • Avoid concomitant use of other antacids (e.g., H2 receptor antagonists) 1
  • Review patient's antibiotic exposure history before selecting a treatment regimen 1

Confirmation of Eradication

  • Wait at least 4 weeks after completing antibiotic therapy before testing for H. pylori eradication 1
  • Use Urea Breath Test (UBT) or monoclonal stool antigen test for confirmation (sensitivity 95%, specificity 90%) 1

Special Considerations

  • Renal impairment: Patients with GFR <30 mL/min should NOT receive the 875 mg dose of amoxicillin; adjust dosing based on severity of impairment 2
  • Pregnancy: Avoid invasive diagnostic procedures unless absolutely necessary; if needed, perform preferably in second trimester 1
  • Breastfeeding: Most medications used for H. pylori treatment are compatible with breastfeeding 1

Common Pitfalls to Avoid

  1. Inadequate treatment duration: 14-day regimens are superior to 7-day regimens (improves eradication by approximately 5%) 1

  2. Ignoring antibiotic resistance patterns: Regional resistance patterns should guide therapy selection; using clarithromycin in high-resistance areas leads to treatment failure 1, 4

  3. Not confirming eradication: Always confirm eradication with UBT or stool antigen test at least 4 weeks after treatment 1

  4. Reusing failed antibiotics: Salvage regimens should avoid antibiotics that were previously used 3, 5

  5. Poor medication timing: Improper PPI timing reduces effectiveness; take 30 minutes before meals 1

References

Guideline

H. pylori Gastritis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

The American journal of gastroenterology, 2017

Research

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

The American journal of gastroenterology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.